Zions Bancorporation N.A. Boosts Stock Position in Balchem Co. (NASDAQ:BCPC)

Zions Bancorporation N.A. lifted its holdings in shares of Balchem Co. (NASDAQ:BCPC) by 17.2% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 10,976 shares of the basic materials company’s stock after buying an additional 1,612 shares during the period. Zions Bancorporation N.A.’s holdings in Balchem were worth $1,932,000 at the end of the most recent reporting period.

Other large investors have also modified their holdings of the company. Janus Henderson Group PLC grew its holdings in shares of Balchem by 21.3% in the 1st quarter. Janus Henderson Group PLC now owns 18,059 shares of the basic materials company’s stock worth $2,795,000 after acquiring an additional 3,176 shares during the period. William Blair Investment Management LLC raised its position in shares of Balchem by 8.4% in the 2nd quarter. William Blair Investment Management LLC now owns 233,831 shares of the basic materials company’s stock worth $35,998,000 after buying an additional 18,104 shares during the period. Oppenheimer Asset Management Inc. raised its position in Balchem by 22.1% in the second quarter. Oppenheimer Asset Management Inc. now owns 20,582 shares of the basic materials company’s stock valued at $3,169,000 after purchasing an additional 3,732 shares during the period. Envestnet Asset Management Inc. raised its position in Balchem by 9.9% in the second quarter. Envestnet Asset Management Inc. now owns 114,253 shares of the basic materials company’s stock valued at $17,589,000 after purchasing an additional 10,285 shares during the period. Finally, Atomi Financial Group Inc. purchased a new position in Balchem in the second quarter valued at about $243,000. 87.91% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several analysts have recently weighed in on BCPC shares. StockNews.com upgraded Balchem from a “hold” rating to a “buy” rating in a research note on Monday, October 28th. HC Wainwright upped their target price on Balchem from $185.00 to $190.00 and gave the company a “buy” rating in a report on Monday, November 4th.

Balchem Stock Performance

Shares of NASDAQ BCPC opened at $176.82 on Friday. The company has a current ratio of 2.98, a quick ratio of 1.90 and a debt-to-equity ratio of 0.21. The stock has a 50 day simple moving average of $172.53 and a 200-day simple moving average of $165.16. The company has a market cap of $5.75 billion, a PE ratio of 47.53, a P/E/G ratio of 5.33 and a beta of 0.65. Balchem Co. has a 12-month low of $120.76 and a 12-month high of $186.03.

Balchem Company Profile

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.